“…8 Calpain 1 (µ-calpain), the lens-specific isoenzyme Lp85, calpain 2 (m-calpain), calpain 3, calpain 10 and the lens-specific Abbreviations: HR, Hazard Ratio; CI, Confidence Interval; N, number of cataract/glaucoma patients # : referent: patients without multiple sclerosis; adjusted for age and gender, smoking, body mass index, systemic glucocorticoids (unless stratified), hypnotics/anxiolytics, anticonvulsants (unless stratified), antidepressants use 6 months prior, diabetes mellitus, chronic obstructive pulmonary disease, cerebrovascular disease, epilepsy and any ocular surgery ever before & : referent: patients without multiple sclerosis; adjusted for age and gender, smoking, body mass index, systemic glucocorticoids (unless stratified), anticonvulsants (unless stratified), serotonin-selective reuptake inhibitors, tricyclic antidepressants, ocular glucocorticoids (unless stratified) use 6 months prior, cerebrovascular disease, epilepsy and any uveitis ever before § : Statistically significant difference (p < 0.05) of the exposure to the medication versus non-exposure to the medication ¥ : Statistically significant difference (p < 0.05) of the exposure to the disease versus non-exposure to the disease isoenzyme Lp82 are known to be active in the lens, with calpain 2 being the most prevalent in mammalian cells. 6,26 In the presence of elevated calcium ion (Ca 2+ ) levels, overactivation of calpains is thought to cause the degradation of lens proteins and changes in the cytoskeletal architecture. 6,7,26 These morphological and biological changes then result in the formation of cataract.…”